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Abstract: Older adults with cardiovascular disease (CVD) often report experiencing significant
cognitive dysfunction in everyday life and exhibit deficits on neuropsychological testing.
However, the relationship between subjective and objective cognitive dysfunction is inconsistent
across studies and requires closer examination. Participants included 84 older adults with
documented CVD and no history of neurological or severe psychiatric disorder. All participants
underwent echocardiogram and neuropsychological assessment and completed self-report
measures of perceived cognitive dysfunction, depression, and health-related quality of life.
Results showed that concerns regarding distractibility and sustained attention were most
common. Level of reported cognitive dysfunction was significantly related to depressive
symptoms, quality of life, and performance on multiple cognitive tests. Exploratory regression
analyses showed that depressive symptoms, physical health-related quality of life, and speeded
sustained attention predicted reports of cognitive dysfunction, whereas demographic variables,
cardiac output, and other cognitive tests did not. Should they be replicated, these findings
suggest that reports of cognitive dysfunction in older adults with CVD largely reflect depressive
symptoms and reduced quality of life.
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There is growing evidence that cardiovascular disease (CVD) is a risk factor for
cognitive dysfunction long prior to onset of stroke or dementia (Mazzucchi et al 1986;
Kalra et al 1993; Grubb et al 1996; Elwood et al 2002; O’Reilly et al 2003; Trojano et
al 2003). These findings are consistent with the notion of vascular cognitive impairment
(VCI), a proposed continuum of cognitive deficits that ranges from “brain at risk” to
vascular dementia (Hachinski and Bowler 1993; Bowler et al 1999). Older adults
with CVD are believed to fall in the middle of this continuum, exhibiting cognitive
deficits and cerebrovascular disease without the functional impairment found in
dementia (Mazzucchi et al 1986; Kalra et al 1993; Grubb et al 1996; Elwood et al
2002; O’Reilly et al 2003; Trojano et al 2003; Cook et al 2004; Kuo and Lipsitz 2004).
Given these findings, it is not surprising that older adults with CVD often report
experiencing significant cognitive dysfunction in everyday life (Khatri et al 1999).
However, less straightforward is the fact that these reports are more closely related
to depressive symptoms than objective test performance (Newman et al 1989; Khatri
et al 1999; Bergh et al 2002). Such findings suggest that older CVD patients lack
insight into their level of cognitive function. Reduced awareness of cognitive function
is not unique to CVD patients and is found in persons with a variety of psychiatric
and neurological conditions. For example, persons with bipolar disorder and patients
in the early stages of dementia also exhibit little awareness of their impairments
(Burdick et al 20005; Spitznagel and Tremont 2005).
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However, methodological concerns of past studies
encourage a re-examination of the relationship between
subjective and objective cognitive impairment in CVD
patients. Careful review shows that previous work often
examined only cardiothoracic surgery patients, selected
predictors from limited domains (ie, only cognitive and
affective), and employed tests that tap cognitive abilities
other than those patients report as being impaired (Newman
et al 1989; Khatri et al 1999; Raja et al 2004). Each of these
methodological choices may distort the observed relationship between reported cognitive dysfunction and test
performance, raising the possibility that reports of cognitive
dysfunction in CVD patients may not be as inaccurate as
originally believed.
To clarify this possibility, the present study examined
self-reported cognitive dysfunction in older adults with
heterogeneous history of CVD. Variables were chosen to
closely match those used in past studies and to extend the
assessment of cognitive abilities that patients reported as
being impaired. Using this method, we hypothesized that
multiple factors, including cognitive performance, would
be related to self-reported cognitive dysfunction of older
adults with CVD.

Methods
The following methods were approved by the local
Institutional Review Board prior to study onset.

Participants
Participants included 84 older adults enrolled in a
prospective study of the neurocognitive consequences of
CVD. They were required to have a documented history of
CVD, a total score on the Mini Mental Status Examination
(MMSE) above cutoff for dementia (Folstein et al 1975),
and no history of neurological or severe psychiatric disorder.
Participants were recruited from cardiology clinic patients
and not selected based on concerns regarding possible
cognitive dysfunction. Participants averaged 69.79 ± 7.87
years of age and 14.41 ± 2.72 years of education. Average
MMSE score (28.52 ± 1.67) and cardiac ejection fraction
(58.87 ± 11.65) were within normal ranges.
In terms of medical history, 46% of participants had a
history of myocardial infarction, 37% coronary artery bypass,
11% valve repair or replacement, 13% heart failure, 74%
hypertension, and 23% type 2 diabetes. Approximately
10% of participants had prior history of mild head injury, 9%
transient ischemic attack, and 13% had history of depression.
214

Instrumentation
Subjective cognitive complaints
The Cognitive Difficulties Scale (CDS) is a pen-and-paper
measure of subjective difficulties in attention, memory,
perception, and psychomotor abilities (McNair and Kahn
1983). It has been used in both healthy and patient samples,
including persons with CVD (McNair and Kahn 1983;
Derouesne et al 1993; Derouesne et al 1999; Khatri et al
1999). The relationship among the CDS, depression, and
cognitive function varies across studies. Although some
studies show a strong relationship between the CDS and
performance on neuropsychological tests, others find the
CDS is more closely related to affective symptoms than
cognitive dysfunction (Gass and Apple 1997; Derouesne et
al 1999; Khatri et al 1999; Burdick et al 2005; Spitznagel
and Tremont 2005).

Neuropsychological tests
All participants completed a neuropsychological test battery
comprising tasks commonly used during clinical neuropsychological evaluation (Table 1). Domains included:
1) Attention (Trailmaking Test Part A [Reitan 1958], Digit
Symbol-Coding [Wechsler 1997], Digit Span [Wechsler
1997], Stroop Color Word Test composite score for Word
and Color trials [Golden 1978]);
2) Executive function (Trail Making Test B [Reitan 1958],
Lexical Fluency [FAS; Eslinger et al 1984], Similarities
[Wechsler 1997], Stroop Color Word Test Interference
[Golden 1978]);
3) Memory (California Verbal Learning Test [Delis et al
1987], Brief Visuospatial Memory Test-Revised
[Benedict 1997]);
4) Language (Boston Naming Test (Kaplan et al 1983],
Category Fluency [Morris et al 1989]);
5) Visuopatial skills (Hooper Visual Organization Test
[Hooper 1983], Block Design [Wechsler 1997]);
6) Motor function (Grooved Pegboard Test for dominant
and nondominant hand [Klove 1963]).

Depression
The Beck Depression Inventory (BDI) assesses vegetative,
affective, and cognitive symptoms of depression and has
been used extensively in patient populations (Beck and Steer
1993; Richter et al 1998).

Quality of life
The Medical Outcomes Study SF-36 (Ware et al 1994) is
a measure of subjective health used extensively in healthy
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and medical populations, including persons with CVD
(Rumsfeld et al 1999, 2001). Its eight domains were
summarized into a Physical Composite Summary (PCS)
and Mental Composite Summary scores (MCS),
representing physical and mental quality of life,
respectively.
Procedure After participants completed a written informed
consent process, all instruments were administered in a oneto-one format by trained research team members.
Participants completed self-report instruments after
neuropsychological testing.
Data analysis Three sets of analyses were conducted to
better understand the self reported cognitive dysfunction of
older adults with CVD. First, bivariate Pearson correlation
was used to determine the relationship between reported
difficulties on the CDS and objective test performance. An
item analysis was then conducted to identify the cognitive
abilities of greatest concern in our sample. Finally,
exploratory regression analyses were conducted to
determine the relative contribution of various factors to CDS
total score. More specifically, we conducted multiple
regression with backward elimination using CDS total score
as the dependent variable. Predictors included demographic
characteristics, measures of cardiovascular disease,
depressive symptoms, quality of life, and performance on
tests that tap the most commonly reported areas of
dysfunction.

Results
Test performance and reported
cognitive dysfunction
Participants typically performed well on
neuropsychological testing, with their combined
performance falling within 1.5 standard deviations of the
normative mean on all tests (Table 1). Bivariate
correlation showed that CDS total score was significantly
related to depressive symptoms on the BDI, quality of
life indices from the SF-36, and performance on multiple
neuropsychological tests (Table 1).

Item analysis
An item analysis was then conducted on the CDS. Corrected
item-total correlations were used to identify the cognitive
tasks of greatest concern to our sample of older adults with
CVD. Results showed that difficulties with distractibility
and sustained attention were most common, followed by
language difficulties (Table 2).
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Table 1 Neuropsychological test performance, impairment
and correlation to reported cognitive dysfunction

Mean (SD)

> 1.5
SD
from
mean

Correlation
to CDS

Reported cognitive difficulties
CDS total score

37.32 (21.56)

No

–

Attention
Trials A
Stroop Word and Color
WAIS-III Digit Span
WAIS-III Symbol Coding

37.76 (12.44)
43.52 (5.83)
17.51 (3.95)
55.40 (13.89)

No
No
No
No

0.251
–0.362
–0.14
–0.191

Executive function
Stroop Interference
Trials B
Lexical Fluency (FAS)
WAIS-III Similarities

–13.65 (6.87)
99.57 (51.47)
36.33 (11.84)
20.96 (5.24)

No
No
No
No

0.15
0.17
–0.17
–0.14

Memory
CVLT Trials 1–5 Total
CVLT Short Free Recall
CVLT Long Free Recall
CVLT Discrimination
BVMT Trials 1–3 Total
BVMT Delayed Recall
BVMT Discrimination

46.58 (11.90)
9.23 (3.29)
9.30 (3.52)
91.33 (7.59)
16.83 (6.98)
6.94 (3.18)
5.05 (1.15)

No
No
No
No
No
No
No

–0.211
–0.10
–0.14
–0.15
–0.231
–0.221
–0.241

54.52 (5.65)
19.90 (5.53)

No
No

–0.191
–0.05

23.44 (3.74)
31.85 (11.18)

No
No

0.03
–0.10

95.91 (26.37)
106.61 (33.41)

No
No

0.10
0.10

Mood
Beck Depression Inventory

5.93 (4.49)

No

0.552

Quality of life
Physical Component Scale
Mental Component Scale

42.73 (9.50)
55.01 (7.73)

No
No

–0.281
–0.452

Test

Language
Boston Naming Test
Category Fluency (Animals)
Visuospatial
HVOT
WAIS-III Block Design
Motor
Grooved Pegboard (D)
Grooved Pegboard (ND)

NOTE: All test scores are raw scores.
1
two-tailed p < 0.05.
2
two-tailed p < 0.01.
Abbreviations: BVMT, Brief Visuospatial Memory Test-Revised; CVLT, California
Verbal Learning Test; CDS, Cognitive Difficulties Scale; D, dominant hand; ND,
nondominant hand; HVOT, Hooper Visual Organization Test; WAIS, Wechsler
Adult Intelligence Scale.

Predicting reported cognitive
dysfunction
Finally, exploratory regression analyses were conducted to
examine the relative contribution of various factors to the
subjective cognitive difficulties of older adults with CVD.
Stepwise regression with backward elimination showed
significant prediction of CDS total score (F[3, 56] = 13.31,
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Table 2 Most common subjective cognitive problems in older
adults with cardiovascular disease
Corrected
item-total
Item

Rank
correlation
1
2
3

I cannot keep my mind on one thing.
I miss the point of what others are saying.
I have trouble getting out information that is at the
tip of my tongue.
4 I find it hard to keep my mind on a task or job.
5 I find it hard to understand what I read.
6 I forget right away what people say to me.
7 I need to have instructions repeated several times.
8 I have trouble describing a program that I just watched
on television.
9 When interrupted during reading, I have trouble finding
my place again.
10 I have to do things very slowly to make sure I’m doing
them right.

0.76
0.75
0.71
0.70
0.68
0.68
0.68
0.66
0.66
0.65

p < 0.001), with the final model accounting for 41.6% of
the variance (Table 3). Three predictors remained significant,
namely: BDI total score, PCS from the SF-36, and speeded
sustained attention from the Stroop Color Word Test.
Demographic variables, cardiac output, and other cognitive
tests were not retained in the final model.

Discussion
The present study is the first to demonstrate that attention
and language abilities are the most common cognitive
Table 3 Predicting cardiovascular disease (CVD) total score in
older adults with CVD
Included variables
Beck Depression Inventory
Physical Quality of Life
Stroop Sustained Attention
Intercept

B

b

p

2.18
–0.48
–1.10
92.80

0.45
–0.21
–0.30

< 0.01
0.05
< 0.01

R2 = 0.42
Adjusted R2 = 0.39
R = 0.66
Excluded variables

B

p

Partial
correlation

Age
Education
Cardiac Output
Mental Quality of Life
Digit Symbol-Coding
CVLT Trial 1
FAS
Boston Naming Test

0.03
–0.12
0.12
–0.19
–0.04
–0.05
0.04
–0.13

0.78
0.26
0.27
0.16
0.77
0.63
0.73
0.22

0.04
–0.15
0.15
–0.19
–0.04
–0.07
0.05
–0.17

Abbreviations: CVLT, California Verbal Learning Test.
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concerns of older CVD patients. Reduced attentional
abilities may be expected in persons with CVD, as they often
show reduced performances on neuropsychological tasks
tapping attention, psychomotor speed, and executive
function (Mazzucchi et al 1986; Kalra et al 1993; Grubb et
al 1996; Elwood et al 2002; O’Reilly et al 2003; Trojano et
al 2003). Language impairment is not traditionally
associated with CVD in the absence of stroke, though wordfinding difficulties are part of both the normal aging process
and a symptom of Alzheimer’s disease (Mackay et al 2002;
Testa et al 2004). Finding that language performance was
within expected ranges implicates normal aging as a likely
cause, but the very early effects of a neurodegenerative
process cannot be fully ruled out. Prospective examination
of our and other samples of CVD patients will help clarify
whether reported word-finding difficulties predict later
conversion to Alzheimer’s disease.
In the present study, reports of cognitive dysfunction
were associated with reduced performance on multiple
cognitive tests. However, the observed relationships were
modest in size (range from –0.19 to –0.36) and explained
little of the total variance. In contrast, depressive symptoms
were closely related to reports of cognitive dysfunction
(r = 0.55). Finding reported cognitive problems are more
closely related to depressive symptoms than actual test
performance is consistent with many past studies (Newman
et al 1989; Khatri et al 1999; Raja et al 2004), though the
exact reason for this relationship remains unclear. Several
possible explanations for this finding exist, including shared
method variance, the known effects of subclinical depression
on cognitive performance, or an as yet unidentified factor
(Wollert and Buchwald 1979).
Analyses also showed that quality of life contributes to
the report of cognitive dysfunction in older adults with CVD.
A relationship between quality of life and reported cognitive
dysfunction has previously been found in healthy and other
patient populations (Collins and Abeles 1996; Dijkstra et al
1998; Levy-Cushman and Abeles 1998). Physical illness is
known to limit cognitive performance in several ways,
including greater distraction, hypervigilance, and preoccupation during tasks (Luoto et al 1999; Gasquione 2000).
These changes would adversely impact the same attentional
abilities reported by our sample as being impaired. However,
once again, the effects of shared method variance on this
relationship cannot be fully excluded and replication in other
samples is needed.
The present findings highlight the complicated
relationship among reported cognitive dysfunction,
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depression, and actual test performance. Like many others,
we found a weak relationship between reported cognitive
dysfunction and actual test performance. This pattern
emerged in our sample with intact test performance.
Interestingly, reported cognitive dysfunction is also
unrelated to actual test performance in Alzheimer’s patients
and psychiatric samples with significant cognitive
impairment (Burdick et al 2005; Spitznagel and Tremont
2005). This pattern suggests two likely explanations. One
possibility is that people generally have little insight into
their level of cognitive function. This inability may well
result from the difficulty in accurately evaluating cognitive
function in everyday life or the effects of limited executive
functioning (which has been associated with reduced
awareness in patient populations (Michon et al 1994; SinghManoux et al 2003; Kuo et al 2004). A second possible
explanation involves the use of cross sectional methodology.
It is possible that between-subject differences (eg, level of
depressive symptoms) obscure more subtle within-subject
changes (eg, reporting a slight change from previous levels).
Prospective examination of reported cognitive dysfunction
and actual test performance are much needed, particularly
studies that collect detailed information regarding subjective
change in cognitive function.
The present study has important implications for
clinicians working with older adults with CVD. Based on
the present findings, CVD patients reporting cognitive
dysfunction are most appropriately referred for neuropsychological evaluation to determine the relative
contribution of depressive symptoms, reduced quality of life,
and actual cognitive impairment to these complaints.
Clinicians may also want to consider additional referral to
exercise or rehabilitation program, as they are associated
with improved mood, quality of life, and cognitive
performance in both healthy and patient populations (Barnes
et al 2003; Stewart et al 2003; Gunstad et al 2005).

Acknowledgments
This study was supported in part by F32-HL74568 (JG),
R01-AG017975 (RAC), and K23-MH065857 (RPH).

References
Barnes D, Yaffe K, Satariano W, et al. 2003. A longitudinal study of
cardiorespiratory fitness and cognitive function in healthy older adults.
J Am Geriat Soc, 51:459–65.
Beck A, Steer R. 1993. Manual for the Beck Depression Inventory. San
Antonio, TX: Psychological Corporation.
Benedict R. 1997. Brief Visuospatial Memory Test-Revised:Professional
Manual. Odessa, FL: Psychological Assessment Resources.

Neuropsychiatric Disease and Treatment 2006:2(2)

Bergh C, Backstrom M, Jonsson H, et al. 2002. In the eye of both patient
and spouse:memory is poor 1 to 2 years after coronary bypass and
angioplasty. Ann Thorac Surg, 74:689–93.
Bowler J, Steenhuis R, Hachinski V. 1999. Conceptual background to
vascular cognitive impairment. Alz Dis Assoc Dis, 13:S30–7.
Burdick K, Endick C, Goldberg J. 2005. Assessing cognitive deficits
in bipolar disorder: are self-reports valid? Psychiatry Res, 136:43–
50.
Collins M, Abeles N. 1996. Subjective memory complaint in the able
elderly. Clin Gerontol, 16:29–54.
Cook I, Leuchter A, Morgan M, et al. 2004. Longitudinal progression of
subclinical structural brain disease in normal aging. Am J Geriatr
Psychiatry, 12:190–200.
Delis D, Kramer J, Kaplan E, et al. 1987. Manual: California Verbal
Learning Test, Adult Version. San Antonio, TX: Psychological
Corporation.
Derouesne C, Dealberto M, Boyer P, et al. 1993. Empirical evaluation of
the ‘Cognitive Difficulties Scale’ for assessment of memory complaints
in general practice:A study of 1628 cognitively normal subjects aged
45–75 years. Int J Geriatr Psychiatry, 8:599–607.
Derouesne C, Thibault S, Lagha-Pierucci S, et al. 1999. Decreased
awareness of cognitive deficits in patients with mild dementia of the
Alzheimer type. Int J Geriatr Psychiatry, 14:1019–30.
Dijkstra J, Van Boxtel M, Houx P, et al. 1998. An operation under general
anesthesia as a risk factor for age-related cognitive decline:Results
from a large cross-sectional population study. J Am Geriatr Soc,
46:1258–65.
Elwood P, Pickering J, Bayer A, et al. 2002. Vascular disease and cognitive
function in older men in the Caerphilly cohort. Age Ageing, 31:43–8.
Folstein M, Folstein S, McHugh P. 1975. Mini-mental state. J Psychiatr
Res, 12:189–98.
Gasquione P. 2000. Postconcussional symptoms in chronic back pain. Appl
Neuropsychol, 7:83–89.
Glassman A, Shapiro P, Ford D, et al. 2003. Cardiovascular health and
depression. J Psychiatr Pract, 9:409–21.
Golden C. 1978. Stroop color and word task: A manual for clinical and
experimental uses. Wood Dale, IL: Stoeling.
Grubb N, O’ Carroll R, Cobbe S, et al. 1996. Chronic memory impairment
after cardiac arrest outside hospital. BMJ, 313:143–6.
Gass C, Apple C. 1997. Cognitive complaints in closed-head
injury:relationship to memory test performance and emotional
disturbance. J Clin Exp Neuropsychol, 19:290–9
Gunstad J, MacGregor K, Paul R, et al. 2005. Cardiac rehabilitation
improves cognitive performance in older adults with cardiovascular
disease. J Cardiopulm Rehab, 25:173–6.
Hachinski V, Bowler J. 1993. Vascular dementia. Neurology, 43:2159–60.
Hooper, H. 1983. The Hooper Visual Organization Test. Los Angeles, CA:
Western Psychological Services.
Kalra L, Jackson S, Swift C. 1993. Psychomotor performance in elderly
hypertensive patients. J Hum Hyperten, 7:279–84.
Kaplan E, Goodglass H, Weintraub S. 1983. Boston Naming Test.
Philadelphia, PA: Lea and Febiger.
Khatri P, Babyak M, Clancy C, et al. 1999. Perception of cognitive function
in older adults following coronary artery bypass surgery. Health
Psychol, 18:301–6.
Klove H. 1963. Clinical neuropsychology. In Forster FM (ed). The medical
clinics of North America. New York, NY: Saunders.
Kuo H, Lipsitz L. 2004. Cerebral white matter changes and geriatric
syndromes:is there a link? J Gerontol A Biol Sci Med Sci, 59:818–26.
Kuo H, Sorond F, Iloputaife I, et al. 2004. Effect of blood pressure on
cognitive functions in elderly persons. J Gerontol A Biol Sci Med Sci,
59:1191–4.
Levy-Cushman J, Abeles N. 1998. Memory complaints in the able elderly.
Clin Gerontol, 19:3–24.
Luoto S, Taimela S, Hurri H, et al. 1999. Mechanisms explaining the link
between low back trouble and deficits in information processing:A
controlled study with follow-up. Spine, 24:255–61.

217

Gunstad et al
Mackay A, Connor L, Albert M, et al. 2002. Noun and verb retrieval in
healthy aging. J Int Neuropsychol Soc, 8:764–70.
Mazzucchi A, Mutti A, Poletti A, et al. 1986. Neuropsychological deficits
in arterial hypertension. Acta Neurol Scand, 73:619–27.
McNair D, Kahn R. 1983. Self-assessment of cognitive deficits. In Ferris
NS, Bartus R (eds). Assessment in geriatric psychopharmacology.
Mark Powley. p 137–43.
Michon A, Deweer B, Pillon B, et al. 1994. Relation of anosognosia to
frontal lobe dysfunction in Alzheimer’s disease. J Neurol Neurosurg
Psychiatry, 577:805–9
Morris J, Heyman A, Mohs R, et al. 1989. The consortium to establish a
registry for Alzheimer’s Disease CERAD. Part I. Clinical and
neuropsychological assessment of Alzheimer’s disease. Neurology,
39:1159–65.
Newman S, Klinger L, Venn G, et al. 1989. Subjective reports of cognition
in relation to assessed cognitive performance following coronary artery
bypass surgery. J Psychosom Res, 33:227–33.
O’Reilly S, Grubb N, O’Carroll R. 2003. In-hospital cardiac arrest leads
to chronic memory impairment. Resuscitation, 58:73–9.
Raja P, Blumenthal J, Doraiswamy P. 2004. Cognitive deficits following
coronary artery bypass grafting:prevalence, prognosis, and therapeutic
strategies. CNS Spectr, 9:763–72.
Reitan R. 1958. Validity of the Trail Making Test as an indicator of organic
brain damage. Percept Mot Skills, 8:271–6.
Richter P, Werner J, Heerlein A, et al. 1998. On the validity of the Beck
Depression Inventory: a review. Psychopathology, 31:160–8.
Rumsfeld J, Magid D, O’Brien M, et al. 2001. Changes in health-related
quality of life following coronary artery bypass graft surgery. Ann
Thorac Surg, 72:2026–32.

218

Rumsfeld J, MaWhinney S, McCarthy M, et al. 1999. Health-related quality
of life as a predictor of mortality following coronary artery bypass
graft surgery. JAMA, 281:1298–303.
Singh-Manoux A, Britton A, Marmot M. 2003. Vascular disease and
cognition function:evidence from the Whitehall II Study. J Am Geriatr
Soc, 51:1445–450.
Spitznagel M, Tremont G. 2005. Cognitive reserve and anosognosia in
questionable and mild dementia. Arch Clin Neuropsychol, 20:
505–15.
Stewart K, Turner K, Bacher A, et al. 2003. Are fitness, activity, and fatness
associated with health-related quality of life and mood in older
persons? J Cardiopulm Rehab, 23:115–21.
Testa J, Ivnik R, Boeve B, et al. 2004. Confrontation naming does not add
incremental diagnostic utility in MCI and Alzheimer’s disease. J Int
Neuropsychol Soc, 10:504–12.
Trojano L, Antonelli Incalzi R, Acanfora D, et al. 2003. Cognitive
impairment:a key feature of congestive heart failure in the elderly.
J Neurol, 250:1456–63.
Ware J, Kosinski M, Keller S. 1994. SF-36 Physical and Mental Health
Summary Scales: a user’s manual, 2nd ed. Boston, MA: The Health
Institute, New England Medical Center.
Wechsler D. 1997. Manual for the Wechsler Adult Intelligence Scale. 3rd
ed. San Antonio, TX: The Psychological Corporation.
Wollert R, Buchwald W. 1979. Subclinical depression and performance
expectations, evaluations of performance, and actual performance.
J Nerv Ment Dis, 167:237–42.

Neuropsychiatric Disease and Treatment 2006:2(2)

